First person - Christiaan Veerman
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Christiaan Veerman is first author on 'Genetic variation in GNB5 causes bradycar...
Saved in:
Format: | Book |
---|---|
Published: |
The Company of Biologists,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_7cfeaf1672f34c7faa2a9836c34f98c0 | ||
042 | |a dc | ||
245 | 0 | 0 | |a First person - Christiaan Veerman |
260 | |b The Company of Biologists, |c 2019-07-01T00:00:00Z. | ||
500 | |a 1754-8403 | ||
500 | |a 1754-8411 | ||
500 | |a 10.1242/dmm.041202 | ||
520 | |a First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Christiaan Veerman is first author on 'Genetic variation in GNB5 causes bradycardia by augmenting the cholinergic response via increased acetylcholine-activated potassium current (IK,Ach)', published in DMM. Christiaan is a resident in cardiology in the lab of Prof. Bezzina at University of Amsterdam, The Netherlands, investigating pathophysiological mechanisms of inheritable cardiac arrhythmia syndromes using human induced pluripotent stem cells. | ||
546 | |a EN | ||
690 | |a Medicine | ||
690 | |a R | ||
690 | |a Pathology | ||
690 | |a RB1-214 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Disease Models & Mechanisms, Vol 12, Iss 7 (2019) | |
787 | 0 | |n http://dmm.biologists.org/content/12/7/dmm041202 | |
787 | 0 | |n https://doaj.org/toc/1754-8403 | |
787 | 0 | |n https://doaj.org/toc/1754-8411 | |
856 | 4 | 1 | |u https://doaj.org/article/7cfeaf1672f34c7faa2a9836c34f98c0 |z Connect to this object online. |